Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs iShares MSCI China ETF (MCHI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs iShares MSCI China ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while iShares MSCI China ETF trades at $52.55 (market cap $5.94B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.1× iShares MSCI China ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and iShares MSCI China ETF for 63 Days on average.
| HALO | MCHI | |
|---|---|---|
Market Cap | $12.58B | $5.94B |
Volume | 2,179,278 | 1,575,471 |
Sector | Health | Broad Market / Factor |
52-Week High | $115.22 | $65.59 |
52-Week Low | $61.63 | $50.48 |
Typical Hold Time | 1 Days | 63 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MCHI trades at $52.55, up 1.76% today, but technical indicators show a bearish trend with moving averages signaling strong selling pressure. The ETF faces headwinds from China's economic challenges including industrial overcapacity and weak domestic consumption. Recent news highlights potential trade tensions ahead of the Trump-Xi summit, though corporate profits surged 26% in Q2 according to Zacks Investment Research (2026-09-08).
The outlook remains cautious due to China's macroeconomic pressures and global trade risks. Investment opportunity exists in MCHI's significant discount to historical valuations versus US indices, but risks include potential export controls and protectionism. The ETF's financial sector benefits from China's steepening yield curve, supporting bank and insurance holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About iShares MSCI China ETF
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →
